Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Philippe Nuss1,21Department of Psychiatry, Hôpital St Antoine, AP-HP, 2UMR 7203, INSERM ERL 1057 – Bioactive Molecules Laboratory, Pierre and Marie Curie University, Paris, FranceAbstract: Lines of evidence coming from many branches of neuroscience indicate that anxiety disorder...
Saved in:
Main Author: | Nuss P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/5de6aded5b584656a8a876f416b70aee |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duloxetine in the treatment of generalized anxiety disorder
by: Trevor R Norman, et al.
Published: (2009) -
The role of duloxetine in the treatment of anxiety disorders
by: Domenico De Berardis, et al.
Published: (2008) -
Differential attentional bias in generalized anxiety disorder and panic disorder
by: Chen J, et al.
Published: (2013) -
Pregabalin for the treatment of generalized anxiety disorder: an update
by: Baldwin DS, et al.
Published: (2013) -
Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
by: Prasko J, et al.
Published: (2016)